Topic: Chronic Myelogenous Leukemia
Question: What are the treatments for Chronic Myelogenous Leukemia ?
Answer: Key Points
                    - There are different types of treatment for patients with chronic myelogenous leukemia.     - Six types of standard treatment are used:         - Targeted therapy     - Chemotherapy      - Biologic therapy     - High-dose chemotherapy with stem cell transplant      - Donor lymphocyte infusion (DLI)     - Surgery         - New types of treatment are being tested in clinical trials.     - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for patients with chronic myelogenous leukemia.
                    Different types of treatment are available for patients with chronic myelogenous leukemia (CML). Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information about new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Six types of standard treatment are used:
                    Targeted therapy     Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Tyrosine kinase inhibitors are targeted therapy drugs used to treat chronic myelogenous leukemia.     Imatinib mesylate, nilotinib, dasatinib, and ponatinib are tyrosine kinase inhibitors that are used to treat CML.    See Drugs Approved for Chronic Myelogenous Leukemia for more information.       Chemotherapy      Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.    See Drugs Approved for Chronic Myelogenous Leukemia for more information.       Biologic therapy     Biologic therapy is a treatment that uses the patients immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the bodys natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.    See Drugs Approved for Chronic Myelogenous Leukemia for more information.       High-dose chemotherapy with stem cell transplant      High-dose chemotherapy with stem cell transplant is a method of giving high doses of chemotherapy and replacing blood-forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the bodys blood cells.    See Drugs Approved for Chronic Myelogenous Leukemia for more information.        Donor lymphocyte infusion (DLI)     Donor lymphocyte infusion (DLI) is a cancer treatment that may be used after stem cell transplant. Lymphocytes (a type of white blood cell) from the stem cell transplant donor are removed from the donors blood and may be frozen for storage. The donors lymphocytes are thawed if they were frozen and then given to the patient through one or more infusions. The lymphocytes see the patients cancer cells as not belonging to the body and attack them.       Surgery      Splenectomy is surgery to remove the spleen.
                
                
                    New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
                
                
                 
								            Treatment Options for Chronic Myelogenous Leukemia
								            
								                
								                    Chronic Phase Chronic Myelogenous Leukemia
								                    Treatment of chronic phase chronic myelogenous leukemia may include the following:         -  Targeted therapy with a tyrosine kinase inhibitor.    -  High-dose chemotherapy with donor stem cell transplant.    - Chemotherapy.    -  Splenectomy.    - A clinical trial of lower-dose chemotherapy with donor stem cell transplant.    - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with chronic phase chronic myelogenous leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
								                
								                
								                    Accelerated Phase Chronic Myelogenous Leukemia
								                    Treatment of accelerated phase chronic myelogenous leukemia may include the following:         -  Donor stem cell transplant.    -  Targeted therapy with a tyrosine kinase inhibitor.    - Tyrosine kinase inhibitor therapy followed by a donor stem cell transplant.    -  Biologic therapy (interferon) with or without chemotherapy.    -  High-dose chemotherapy.    - Chemotherapy.    -  Transfusion therapy to replace red blood cells, platelets, and sometimes white blood cells, to relieve symptoms and improve quality of life.    - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with accelerated phase chronic myelogenous leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
								                
								                
								                    Blastic Phase Chronic Myelogenous Leukemia
								                    Treatment of blastic phase chronic myelogenous leukemia may include the following:         -  Targeted therapy with a tyrosine kinase inhibitor.    -  Chemotherapy using one or more drugs.    -  High-dose chemotherapy.    -  Donor stem cell transplant.    - Chemotherapy as palliative therapy to relieve symptoms and improve quality of life.    - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with blastic phase chronic myelogenous leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
								                
								                
								                    Relapsed Chronic Myelogenous Leukemia
								                    Treatment of relapsed chronic myelogenous leukemia may include the following:         -  Targeted therapy with a tyrosine kinase inhibitor.    -  Donor stem cell transplant.    -  Chemotherapy.     -  Donor lymphocyte infusion.    -  Biologic therapy (interferon).    - A clinical trial of new types or higher doses of targeted therapy or donor stem cell transplant.         Check the list of NCI-supported cancer clinical trials that are now accepting patients with relapsing chronic myelogenous leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
Source: CancerGov